Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 4,047
Active & Responsive
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Stamford CT, New Bedford MA, Needham MA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06143956
Phase 2, Recruiting
Active & Responsive
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Location: Hauppauge NY, Bethlehem PA, Cherry Hill NJ,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07440225
Phase 2, Phase 3, Recruiting
Active & Responsive
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Lake Success NY, Wilmington DE, Washington D.C. DC,
Sponsor: Ascendis Pharma A/S
Sex: All
Age: 2 - 17
Code: NCT07221851
Phase 3, Recruiting
Active & Responsive
International Weight Control Registry
for
Weight Loss, Overweight, Obesity
Location: West Point NY, Boston MA, Durham NH, Birmingham AL,
Location: Stony Brook NY, Philadelphia PA, Buffalo NY, Raleigh NC,
Sponsor: Cerus Endovascular, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06693011
Recruiting
Active & Responsive
ME/CFS: Activity Patterns and Autonomic Dysfunction
for
Chronic Fatigue Syndrome
Location: Stony Brook NY
Sponsor: Stony Brook University
Sex: All
Age: 18 - 65
Code: NCT02948556
Recruiting
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: Stony Brook NY, Silver Spring MD, Pittsburgh PA,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase 3, Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Stony Brook NY, Chadds Ford PA, Wilmington DE,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07441681
Phase 3, Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity